Olema Pharmaceuticals, Inc. (OLMA)
15.06
-0.06
(-0.36%)
USD |
NASDAQ |
Apr 02, 16:00
15.06
0.00 (0.00%)
After-Hours: 17:49
Olema Pharmaceuticals Research and Development Expense (TTM) : 157.70M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| EyePoint Plc | 221.04M |
| CytomX Therapeutics, Inc. | 67.60M |
| Corvus Pharmaceuticals, Inc. | 33.72M |
| Protagonist Therapeutics, Inc. | 159.29M |
| Oric Pharmaceuticals, Inc. | 109.82M |